SpyGlass Pharma, Inc. SGP
$18.20
▲ +1.93% 24H
About
SpyGlass Pharma, Inc. is a late-stage biopharmaceutical company specializing in sustained drug delivery solutions for chronic eye conditions, particularly open-angle glaucoma and ocular hypertension. Founded in 2019 by Malik Y. Kahook, M.D., and Glenn Sussman, the company develops innovative platforms that integrate ap…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees65
TickerSGP
Statistics
Market Cap$608.3M
Revenue (TTM)$0
Net Income-$39.9M
Net Margin—
EPS$-1.25
P/E-14.45
P/S—
P/B2.42
EV/EBITDA-17.22
ROE-67.7%
Dividend Yield—
Price$18.20
Data: Twelve Data · Revenue = mcap / P/S